Andere Sprachen Beijing SL Pharmaceutical Co., Ltd.

Aktien

002038

CNE000001L31

002038

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 10.05.2024			% 5 Tage	% 1. Jan.
8,75 ^CNY	-2,34 %		+1,51 %	-14,13 %

23.04.	Beijing SL Pharmaceutical Co. Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
2023	Beijing SL Pharmaceutical Co. Ltd. meldet Ergebnis für die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023	24.04.
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23.04.
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Chinese Shares Extend Losses on Middle East Conflict; Beijing SL Pharmaceutical Slumps Despite Drug Trial Approval	20.10.23
Beijing SL Pharmaceutical Gets Nod to Trial Anti-Hepatitis C Drug; Shares Drop 10%	20.10.23
Kanghui Pharma Denies Speculations of Unit’s Involvement in Production of Weight-Loss Drugs	17.10.23
Beijing SL Pharmaceutical Gets Certificate for PEGylated Human Granulocyte Stimulating Factor Injection; Shares Up 3%	25.09.23
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24.08.23
Beijing SL Pharma Gets Registration Certificate for Cancer Drug	20.06.23
Beijing SL Pharmaceutical Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 28 June 2023	26.05.23
Beijing Sl Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	26.04.23
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25.04.23
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	25.04.23
Beijing SL Pharma Registers Diabetes Drug	23.03.23
Beijing SL Pharmaceutical's Flu Medicine Gets Marketing Nod in China	23.12.22
Beijing SL Pharmaceutical Gets Regulatory Approval for Argatroban Injection	08.11.22
Beijing SL Pharmaceutical Co., Ltd. agreed to acquire remaining 30% stake in Xinxiang SL Pharmaceutical Co., Ltd. from Xinxiang Chemical Fiber Co., Ltd. for CNY 10.8 million.	31.10.22
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25.10.22
Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	23.08.22
Beijing SL Pharmaceutical Co., Ltd. Implements Final Dividend on Share A for 2021, Payable on June 29, 2022	22.06.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Beijing SL Pharmaceutical Co., Ltd.

Aktien

002038

CNE000001L31

002038

Andere Sprachen

Filter